Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.090
-0.040 (-3.54%)
At close: Jan 9, 2026, 4:00 PM EST
1.070
-0.020 (-1.83%)
After-hours: Jan 9, 2026, 6:26 PM EST
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $92.43 million as of January 9, 2026. Its market cap has increased by 32.53% in one year.
Market Cap
92.43M
Enterprise Value
92.73M
1-Year Change
32.53%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $92.43M, an increase of 2.46%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 95.82M | 13.00% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |